Net Income (Loss) Attributable to Parent in USD of IN8BIO, INC. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
IN8BIO, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2020 to Q3 2025.
  • IN8BIO, INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$3.85M, a 45.6% increase year-over-year.
  • IN8BIO, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$20.7M, a 35.2% increase year-over-year.
  • IN8BIO, INC. annual Net Income (Loss) Attributable to Parent for 2024 was -$30.4M, a 1.43% decline from 2023.
  • IN8BIO, INC. annual Net Income (Loss) Attributable to Parent for 2023 was -$30M, a 5.21% decline from 2022.
  • IN8BIO, INC. annual Net Income (Loss) Attributable to Parent for 2022 was -$28.5M, a 94.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

IN8BIO, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$20.7M -$3.85M +$3.23M +45.6% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$23.9M -$5.09M +$3.54M +41% 01 Apr 2025 30 Jun 2025 10-Q 06 Nov 2025
Q1 2025 -$27.4M -$5.55M +$3.01M +35.2% 01 Jan 2025 31 Mar 2025 10-Q 06 Nov 2025
Q4 2024 -$30.4M -$6.16M +$1.44M +18.9% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 -$31.9M -$7.09M +$83K +1.16% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$32M -$8.63M -$914K -11.8% 01 Apr 2024 30 Jun 2024 10-Q 06 Nov 2025
Q1 2024 -$31M -$8.56M -$1.04M -13.8% 01 Jan 2024 31 Mar 2024 10-Q 06 Nov 2025
Q4 2023 -$30M -$7.6M +$200K +2.57% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 -$30.2M -$7.17M +$230K +3.11% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$30.4M -$7.72M -$536K -7.47% 01 Apr 2023 30 Jun 2023 10-Q 12 Nov 2024
Q1 2023 -$29.9M -$7.53M -$1.38M -22.5% 01 Jan 2023 31 Mar 2023 10-Q 12 Nov 2024
Q4 2022 -$28.5M -$7.8M -$1.95M -33.3% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024
Q3 2022 -$26.6M -$7.4M -$4.01M -118% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$22.6M -$7.18M -$4.13M -135% 01 Apr 2022 30 Jun 2022 10-Q 09 Nov 2023
Q1 2022 -$18.4M -$6.15M -$3.78M -160% 01 Jan 2022 31 Mar 2022 10-Q 09 Nov 2023
Q4 2021 -$14.7M -$5.85M -$3.54M -153% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$11.1M -$3.39M -$1.71M -102% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$9.41M -$3.05M -$176K -6.12% 01 Apr 2021 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$9.23M -$2.36M -$672K -39.7% 01 Jan 2021 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$8.56M -$2.31M 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 -$1.68M 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$2.87M 01 Apr 2020 30 Jun 2020 10-Q 10 Nov 2021
Q1 2020 -$1.69M 01 Jan 2020 31 Mar 2020 10-Q 10 Nov 2021

IN8BIO, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$30.4M -$430K -1.43% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 -$30M -$1.49M -5.21% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 -$28.5M -$13.9M -94.6% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024
2021 -$14.7M -$6.1M -71.2% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$8.56M 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.